Clinical Trials Directory

Trials / Completed

CompletedNCT04593004

Teledermatology vs. Face-to-Face Visits in the Follow-Up of Patients With Acne

Randomized Open-Label Trial Comparing Teledermatology vs. Face-to-Face Consultation in the Follow-Up of Patients With Mild-to-Moderate Acne

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years – 28 Years
Healthy volunteers
Not accepted

Summary

Acne vulgaris is a common cutaneous inflammatory condition of sebaceous follicles that can profoundly affect patients' quality of life, especially at a young age. In this context the use of teledermatology can potentially reduce the healthcare costs associated to traditional consultations as well as the costs related to travel and loss of school/working time for the patient, with a clear benefit for the whole community. Since 2016, the Department of Dermatology at Inselspital Hospital in Bern has a portal and a smartphone app for online advice service. Hereby the investigators propose to explicitly investigate the efficacy of this system in reducing healthcare costs as compared to traditional face-to-face consultations, in a cohort of patients with mild-to-moderate acne vulgaris.

Conditions

Interventions

TypeNameDescription
DEVICETeledermatologyPatients will be assessed and followed-up by trained physicians through a store-and-forward system (teledermatology online service - Evita® app), which allows patients to upload pictures of skin areas affected by acne as well as their symptoms or questions related to their disease.
OTHERFace-to-face consultationPatients will be assessed and followed-up by trained physicians through regular face-to-face outpatient consultations.

Timeline

Start date
2020-10-07
Primary completion
2022-06-20
Completion
2022-06-20
First posted
2020-10-19
Last updated
2024-12-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04593004. Inclusion in this directory is not an endorsement.